Furthermore, ERK activity is implicated in the mechanisms of apoptosis induced by several DNA-damaging chemotherapeutic reagents for cancer treatment as exemplified by cisplatin or etoposide (or doxorubicin) [19,20,21]. Here, MAPK1 is linked to cancer.